Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”

Detalles Bibliográficos
Autores principales: Lallana, Sofia, Siegler, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363468/
https://www.ncbi.nlm.nih.gov/pubmed/34509250
http://dx.doi.org/10.1016/j.jocn.2021.08.006
_version_ 1783738359780212736
author Lallana, Sofia
Siegler, James E.
author_facet Lallana, Sofia
Siegler, James E.
author_sort Lallana, Sofia
collection PubMed
description
format Online
Article
Text
id pubmed-8363468
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83634682021-08-15 Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19” Lallana, Sofia Siegler, James E. J Clin Neurosci Article Elsevier Ltd. 2021-10 2021-08-14 /pmc/articles/PMC8363468/ /pubmed/34509250 http://dx.doi.org/10.1016/j.jocn.2021.08.006 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lallana, Sofia
Siegler, James E.
Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
title Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
title_full Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
title_fullStr Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
title_full_unstemmed Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
title_short Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
title_sort response to correspondence concerning “posterior reversible encephalopathy syndrome (pres) associated with covid-19”
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363468/
https://www.ncbi.nlm.nih.gov/pubmed/34509250
http://dx.doi.org/10.1016/j.jocn.2021.08.006
work_keys_str_mv AT lallanasofia responsetocorrespondenceconcerningposteriorreversibleencephalopathysyndromepresassociatedwithcovid19
AT sieglerjamese responsetocorrespondenceconcerningposteriorreversibleencephalopathysyndromepresassociatedwithcovid19

Ejemplares similares